P&G Crest Whitestrips Patents Repel ‘Indefiniteness’ Challenge
This article was originally published in The Tan Sheet
P&G prevails in U.S. district court arguing that three private-label tooth-whitening strip firms infringed three off its patents for Crest Whitestrips. The defendants plan to appeal the ruling against their motion that two of P&G’s patents are invalid.
You may also be interested in...
Bayer buys herbal firm; NBTY notes bright spots, hires international leader; Neptune prepares to rebuild; P&G suit targets CAO’s tooth whiteners; CSPI supports restricting St. John’s wort; Coppertone schools parents; Hillary Clinton will speak at NACDS Total Store Expo.
Perrigo divests personal hygiene assets; P&G sues whitening strip private labeler; Purimune contamination prompts Baby Move recall; FDA sounds alarm on Oto-Ease recall; more news In Brief.
Avadim Health could get FTC scrutiny after it declines to comply with two findings by an industry self-regulation group to discontinue 26 claims for its Theraworx Relief homeopathic products. It says the analysis “misapplied the well-recognized standards of substantiation” established by FTC.